Spruce Biosciences Inc (NASDAQ: SPRB) closed the day trading at $0.79 down -5.95% from the previous closing price of $0.84. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 630096 shares were traded.
Ratios:
For a better understanding of SPRB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.18 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on March 14, 2024, Downgraded its rating to Sector Perform and sets its target price to $2 from $9 previously.
On March 14, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $9 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Novo Holdings A/S sold 465,021 shares for $0.75 per share. The transaction valued at 350,951 led to the insider holds 2,550,000 shares of the business.
Novo Holdings A/S sold 359,979 shares of SPRB for $264,081 on Mar 20 ’24. The 10% Owner now owns 3,015,021 shares after completing the transaction at $0.73 per share. On Mar 19 ’24, another insider, Novo Holdings A/S, who serves as the 10% Owner of the company, sold 593,000 shares for $0.76 each. As a result, the insider received 447,715 and left with 3,375,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRB now has a Market Capitalization of 32.51M and an Enterprise Value of -59.22M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.22 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at -5.87 whereas that against EBITDA is 1.25.
Stock Price History:
Over the past 52 weeks, SPRB has reached a high of $5.95, while it has fallen to a 52-week low of $0.68. The 50-Day Moving Average of the stock is 3.3303, while the 200-Day Moving Average is calculated to be 2.3283.
Shares Statistics:
Over the past 3-months, SPRB traded about 1.27M shares per day on average, while over the past 10 days, SPRB traded about 1.3M shares per day. A total of 41.03M shares are outstanding, with a floating share count of 21.95M. Insiders hold about 46.65% of the company’s shares, while institutions hold 36.72% stake in the company. Shares short for SPRB as of Mar 15, 2024 were 189.29k with a Short Ratio of 0.15, compared to 50.25k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.46% and a Short% of Float of 0.58%.
Earnings Estimates
Current recommendations for the stock of the company come from 7 analysts. On average, analysts expect EPS of -$0.29 for the current quarter, with a high estimate of -$0.19 and a low estimate of -$0.34, while EPS last year was -$0.4. The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.2 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.67 and -$1.59 for the fiscal current year, implying an average EPS of -$1.12. EPS for the following year is -$1.01, with 6 analysts recommending between -$0.55 and -$1.87.
